FDA Calls for Nominations for TPSAC Members.

Sep.27.2022
FDA Calls for Nominations for TPSAC Members.
The FDA is seeking nominations for two individuals to serve on the Tobacco Products Scientific Advisory Committee.

The US Food and Drug Administration's Center for Tobacco Products is currently seeking nominations for two individuals to serve as voting members of the Tobacco Product Scientific Advisory Committee (TPSAC). According to the FDA website, individuals are able to self-nominate or be nominated by any interested person or organization.


Source: Postmodern Studio


Nominations received by November 25, 2022 or before will be given priority consideration. Nominations received after November 25, 2022 will be considered for future openings.


The Tobacco Products Scientific Advisory Committee (TPSAC) provides advice to the Center for Tobacco Products (CTP) of the U.S. Food and Drug Administration (FDA) regarding its responsibilities in regulating tobacco products. The committee reviews and evaluates tobacco product safety, dependence, and health issues, and provides appropriate recommendations, information, and advice to the FDA Commissioner.


This notice has been published in the Federal Gazette.


Disclaimer:


This article is compiled from third-party information and is intended for industry discussions and learning purposes only.


This article does not reflect the views of 2FIRSTS, nor can 2FIRSTS confirm the truthfulness and accuracy of the article's content. The translation of this article is only intended for communication and research purposes within the industry.


Due to limitations in the translator's proficiency, the translated article may not accurately convey the original meaning. Therefore, it is recommended to refer to the original article for accuracy.


In regards to any domestic, Hong Kong, Macau, Taiwan or international issues, 2FIRSTS maintains complete alignment with the Chinese government's statements and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation
KT&G Moves Ahead With Oral Nicotine Product Development and Pilot Line Preparation
According to a Korean media report, KT&G is developing a smokeless nicotine product that delivers nicotine through oral absorption and is preparing a pilot production line for research and development.
Apr.08 by 2FIRSTS.ai
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
FDA Renews Exposure Modification Authorization for IQOS Devices and Three HeatSticks Products
FDA Renews Exposure Modification Authorization for IQOS Devices and Three HeatSticks Products
U.S. Food and Drug Administration renewed modified risk granted orders for five IQOS products from Philip Morris Products S.A., including two IQOS system holders and chargers and three HeatSticks products. Under the renewed orders, the products may continue to be marketed with an exposure modification claim.
Apr.20 by 2FIRSTS.ai
EU Launches Online Feedback as TPD Revision Enters New Milestone
EU Launches Online Feedback as TPD Revision Enters New Milestone
The European Commission has opened an online call for evidence on revising EU tobacco products and advertising rules, marking a new phase in the TPD/TAD review. Policy options may cover novel products, flavours, packaging, digital marketing and advertising. A 2Firsts review of 855 early submissions shows rapid engagement and recurring debate over differentiated regulation, harm reduction, youth protection, illicit trade and economic impact.
Special Report
May.21
Japan to Raise Heated Tobacco Prices From April; BAT Japan Keeps Prices Unchanged for 38 glo Tobacco Stick Products
Japan to Raise Heated Tobacco Prices From April; BAT Japan Keeps Prices Unchanged for 38 glo Tobacco Stick Products
Japan will implement price increases centered on heated tobacco products from April 1, 2026, following a tobacco tax hike. BAT Japan has decided to keep current prices unchanged for 38 glo-compatible tobacco stick products across the Velo, neo, Lucky Strike, and Kent lines.
Mar.30 by 2FIRSTS.ai